William Blair & Co.: Alto Neuroscience, Inc. - Initiation of Research Coverage
February 28, 2024
February 28, 2024
CHICAGO, Illinois, Feb. 28 (TNSres) -- William Blair and Co., an investment bank and financial services company, issued the following news:
William Blair initiated research coverage of Alto Neuroscience, Inc. (ANRO $13.72), a company focused on developing novel therapies for high-unmet-need indications in psychiatry supported by AI-enabled precision approaches to identify response biomarkers.
Analyst Myles Minter, Ph.D., estimated that for its lead assets ALTO-100 and A . . .
William Blair initiated research coverage of Alto Neuroscience, Inc. (ANRO $13.72), a company focused on developing novel therapies for high-unmet-need indications in psychiatry supported by AI-enabled precision approaches to identify response biomarkers.
Analyst Myles Minter, Ph.D., estimated that for its lead assets ALTO-100 and A . . .